ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Heterogeneity Analysis of Bladder Cancer Based on DNA Methylation Molecular Profiling

Wang, Shuyu; Xu, Dali; Gao, Bo; Yan, Shuhan; Sun, Yiwei; Tang, Xinxing; Jiao, Yanjia; Huang, Shan*; Zhang, Shumei*东北林业大学; 哈尔滨医科大学
Frontiers in Oncology2022-6-7DOI: 10.3389/fonc.2022.915542
2被引16阅读
引用收藏
分享

摘要

Bladder cancer is a highly complex and heterogeneous malignancy. Tumor heterogeneity is a barrier to effective diagnosis and treatment of bladder cancer. Human carcinogenesis is closely related to abnormal gene expression, and DNA methylation is an important regulatory factor of gene expression. Therefore, it is of great significance for bladder cancer research to characterize tumor heterogeneity by integrating genetic and epigenetic characteristics. This study explored specific molecular subtypes based on DNA methylation status and identified subtype-specific characteristics using patient samples from the TCGA database with DNA methylation and gene expression were measured simultaneously. The results were validated using an independent cohort from GEO database. Four DNA methylation molecular subtypes of bladder cancer were obtained with different prognostic states. In addition, subtype-specific DNA methylation markers were identified using an information entropy-based algorithm to represent the unique molecular characteristics of the subtype and verified in the test set. The results of this study can provide an important reference for clinicians to make treatment decisions.

学科与关键词

关键词
bladder cancerDNA methylationmolecular subtypessubtype specific biomarkersheterogeneity analysis
相关
加载中…
  • Identification of Prognostic Biomarkers for Bladder Cancer Based on DNA Methylation Profile
    Zhang, Shumei; Zhang, Jingyu; Zhang, Qichao; Liang, Yingjian; Du, Youwen; Wang, Guohua*Frontiers in Cell and Developmental Biology, 2022, 9: 817086.被引 11
  • Excavation of Molecular Subtypes of Endometrial Cancer Based on DNA Methylation
    Liu, Yujie; Gu, Yue; Zhang, Mengyan; Zeng, Jiaqi; Wang, Yangyang; Wang, Hongli; Liu, Xueting; Liu, Sijia; Wang, Zhao; Wang, Yuan; Wang, Le; Zhang, Yunyan*Genes, 2022, 13(11): 2106.
  • Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer
    Roperch Jean Pierre; Grandchamp Bernard; Desgrandchamps Francois; Mongiat Artus Pierre; Ravery Vincent; Ouzaid Idir; Roupret Morgan; Phe Veronique; Ciofu Calin; Tubach Florence; Cussenot Olivier; Incitti RobertoBMC Cancer, 2016, 16: 704.被引 45
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2022-06-07
卷期
第 12 卷
页码
915542
DOI
10.3389/fonc.2022.915542
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [62002057, 62002087, 62172129]; Fundamental Research Funds for the Central Universities [2572020BH02]; Innovation and Entrepreneurship Training Program for Students of Northeast Forestry University [DC2020141]

作者

  • W

    Wang, Shuyu (第一作者)

    northeast forestry univ

  • X

    Xu, Dali

    northeast forestry univ

查看全部 9 位作者收起作者
  • G

    Gao, Bo

    2 · harbin med univ

  • Y

    Yan, Shuhan

    northeast forestry univ

  • S

    Sun, Yiwei

    northeast forestry univ

  • T

    Tang, Xinxing

    northeast forestry univ

  • J

    Jiao, Yanjia

    northeast forestry univ

  • H

    Huang, Shan (通讯)

    2 · harbin med univ

  • Z

    Zhang, Shumei (通讯)

    northeast forestry univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417